Facial injectors are used to inject the facial filler products, such as collagen, calcium hydroxyl apatite, and hyaluronic acid, to rejuvenate facial skin by eliminating or reducing wrinkles, enhancing lips, raising scar depressions, and substituting soft-tissue volume loss.
Increase in beauty consciousness, rise in awareness about the facial injections, growth in demand of non-surgical & minimally-invasive cosmetic surgeries, and advent of new products drive the market growth.
The global Facial Injectors market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Facial Injectors volume and value at global level, regional level and company level. From a global perspective, this report represents overall Facial Injectors market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Facial Injectors in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Facial Injectors manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
GALDERMA INDIA Pvt. Ltd
Revance Therapeutics, Inc
Cynosure India Private Limited
Valeant Pharmaceuticals International, Inc
Segment by Regions
Segment by Type
Dermal Fillers/Injectable Implants (Hyaluronic Acid, Collagen Fillers and Synthetic Fillers)
Anti-Aging/Anti-Wrinkle Injections (Botulinum Toxin A and Poly-L-Lactic Acid (PLLA) Microparticles)
Segment by Application
Dermatology Research Institutes